Document is current
Any future updates will be listed below
-
Authors
Hodan, Rachel
Picus, Miles
Stanclift, Caroline
Ormond, Kelly E.
Pichardo, Jennifer Morales
Kurian., Allison W.
Ricker, Charité
Idos, Gregory E.
-
Funding
Funding for this research was provided by:
Myriad Genetics (No. KL2-TR000131 and P30-CA014089, No. KL2-TR000131 and P30-CA014089, No. KL2-TR000131 and P30-CA014089)
Anton B. Burg Foundation
Jane and Kris Popovich Chair in Cancer Research
Daniel and Maryann Fong
- License Information
-
More Information
Article History
Received: 15 December 2023
Accepted: 18 May 2024
First Online: 30 May 2024
Declarations
:
: Gregory Idos: Research Funding: Myriad Genetics (Inst). Allison W. Kurian: Research Funding: Myriad Genetics (Inst) Other Relationship: Ambry Genetics, Color Genomics, GeneDx, BioReference, InVitae, Genentech. Charité Ricker: Research Funding: Myriad Genetics (Inst). The remaining authors declare that they have no competing interests.
: Gregory Idos: Research Funding: Myriad Genetics (Inst).Allison W. Kurian: Research Funding: Myriad Genetics (Inst) Other Relationship: Ambry Genetics, Color Genomics, GeneDx, BioReference, InVitae, Genentech.Charité Ricker: Research Funding: Myriad Genetics (Inst).The remaining authors declare that they have no competing interests.Approval to conduct this human subjects research was obtained by both the University of Southern California and Stanford University institutional review board. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
